The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vazquez, A.
Right arrow Articles by Maizel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vazquez, A.
Right arrow Articles by Maizel, A.

The Journal of Immunology, Vol 142, Issue 1 94-99, Copyright © 1989 by American Association of Immunologists

ARTICLES

Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4

A Vazquez, S Mills and A Maizel
Roger Williams General Hospital, Department of Pathology, Providence, RI 02908.

Several human T cell derived factors capable of stimulating human B cells to synthesize DNA have been previously described. One such factor exhibits an apparent m.w. of 50,000 Da and has been termed 50-kDa-B cell growth factor (BCGF). In this report, we show that a human B cell proliferation pathway based on the sequential action of anti-mu antibody, 50-kDa-BCGF and IL-2 is inhibited in the presence of human rIL-4. Although IL-4 itself is capable of triggering B cell DNA synthesis as measured at 72 h, this lymphokine inhibits, in a dose- related manner, the 50-kDa-BCGF driven response of B cells to IL-2 when such proliferation is determined after 144 h. This inhibition takes place at an early step of the B cell activation and does not require the presence of IL-4 during the whole culture period. Such inhibitory activity of IL-4 is specific to the IL-2-induced B cell proliferation because DNA synthesis measured in the presence of semi-purified human 12-kDa-BCGF is not affected by the presence of IL-4. Our results suggest that a particular pathway of human B cell activation leading to the proliferation of these cells in the presence of IL-2 could be either up- or down-modulated by 50-kDa-BCGF and IL-4, respectively.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. K. A. Mongini, J. K. Inman, H. Han, S. L. Kalled, R. J. Fattah, and S. McCormick
Innate Immunity and Human B Cell Clonal Expansion: Effects on the Recirculating B2 Subpopulation
J. Immunol., November 1, 2005; 175(9): 6143 - 6154.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Roy, C. H. Kim, and E. C. Butcher
Cytokine Control of Memory B Cell Homing Machinery
J. Immunol., August 15, 2002; 169(4): 1676 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Ford, C. Sheehan, C. Girasole, R. Priester, N. Kouttab, J. Tigges, T. C. King, A. Luciani, J. W. Morgan, and A. L. Maizel
The Human B Cell Response to IL-13 Is Dependent on Cellular Phenotype as Well as Mode of Activation
J. Immunol., September 15, 1999; 163(6): 3185 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Russell, A. Keegan, N Harada, Y Nakamura, M Noguchi, P Leland, M. Friedmann, A Miyajima, R. Puri, W. Paul, et al.
Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor
Science, December 17, 1993; 262(5141): 1880 - 1883.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.